Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma and liposaroma (NCT03886311).

Authors: Anmol Dia Agarwal, Samantha Jeffrey, Jason Ballon, Princess "Angela" Savage, Vanessa Xayasak, Lauren Woolsey, Sarosh Syed, Ania M. Moradkhani, Victoria S. Chua-Alcala, Neal Shiv Chawla, Erlinda Maria Gordon, Sant P. Chawla

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23560

Source: Full article

---

Abstract

e23560